Evidence map›Paper›PMID 27210267›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2016

Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case-control study.

Robert Colebunders, Michel Mandro, John L Mokili, Gisele Mucinya, Germain Mambandu, Kenneth Pfarr, Ingrid Reiter-Owona, Achim Hoerauf, Floribert Tepage, Bethanie Levick and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. The Efficacy of Doxycycline Treatment onThe American journal of tropical medicine and hygiene · 2019
    Trial
  4. Article
  5. Article
  6. Increased HIV Incidence inPathogens (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 5 countries.

Robert ColebundersGlobal Health Institute, University of Antwerp, Antwerp, Belgium. Electronic address: robert.colebunders@uantwerpen.be.
Michel MandroProvincial Health Division Ituri, Ministry of Health, Bunia, Democratic Republic of the Congo.
John L MokiliBiology Department, San Diego State University, San Diego, USA.
Gisele MucinyaMedical Doctor Bunia, Bunia, Democratic Republic of the Congo.
Germain MambanduProvincial Ministry of Public Health, Ministry of Health, Kisangani, Democratic Republic of the Congo.
Kenneth PfarrInstitute for Medical Microbiology, Immunology and Parasitology, University Hospital of Bonn, Bonn, Germany.
Ingrid Reiter-OwonaInstitute for Medical Microbiology, Immunology and Parasitology, University Hospital of Bonn, Bonn, Germany.
Achim HoeraufInstitute for Medical Microbiology, Immunology and Parasitology, University Hospital of Bonn, Bonn, Germany.
Floribert TepageNational Onchocerciasis Control Program, Ministry of Health, Kisangani, Democratic Republic of the Congo.
Bethanie LevickInstitute of Integrative Biology, School of Biological Sciences, University of Liverpool, Liverpool, UK.
Michael BegonInstitute of Integrative Biology, School of Biological Sciences, University of Liverpool, Liverpool, UK.
Anne LaudisoitGlobal Health Institute, University of Antwerp, Antwerp, Belgium; Institute of Integrative Biology, School of Biological Sciences, University of Liverpool, Liverpool, UK.
University Hospital Bonn · DEMinistry of Public Health · CDUniversity of Antwerp · BEUniversity of Liverpool · GBSan Diego State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe reason for the high prevalence of epilepsy in onchocerciasis endemic areas remains unknown. The aim of this study was to detect risk factors associated with epilepsy in a region endemic for onchocerciasis.

methodsIn June 2014, a case-control study was performed in Titule, Bas-Uélé Province in the Democratic Republic of the Congo. Individuals with unprovoked convulsive epilepsy of unknown aetiology were enrolled as cases (n=59). Healthy members of families without cases of epilepsy in the same village were recruited as controls (n=61). A multivariate binomial logistic regression analysis was performed to identify potential risk factors associated with epilepsy. To evaluate the potential protective effect of ivermectin treatment on the development of epilepsy, a nested age-matched case-control study was performed including only those who were eligible for ivermectin treatment in the year before they developed epilepsy.

resultsSuspected onchocerciasis skin lesions were more often present in cases than in controls: 12/41 (29%) vs. 1/56 (2%), respectively (odds ratio (OR) 20.26, 95% confidence interval (CI) 2.42-170; p<0.01). Ivermectin had been taken 7 months earlier in 29/59 (49%) cases and 29/61 (48%) controls. Onchocerca volvulus (OV) DNA was detected by PCR in skin snips in 26/34 cases (76%) and 10/14 controls (71%) (p=0.7), and there was presence of OV IgG4 antibodies in 35/48 (73%) cases and 15/18 (83%) controls (p=0.5). OV DNA was not detected in the cerebrospinal fluid of cases (controls not tested). Both cases and controls reported frequent bites by blackflies (Diptera, Simuliidae). Bathing daily as opposed to less often (OR 16.7, 95% CI 2.2-125.8; p<0.01), bathing between 11 a.m. and 4 p.m. (OR 12.7, 95% CI 1.6-103.7; p=0.02), and washing clothes between 11 a.m. and 4 p.m. (OR 10.9, 95% CI 1.5-77.3; p=0.02) were all independently associated with epilepsy. Blood screening by specific PCR tests for Toxoplasma and Wuchereria bancrofti was negative in all cases and controls. A Loa loa infestation was found in only one case and one control by PCR and Giemsa smear. Antibodies to Taenia solium, Toxocara, and Trypanosoma sp were not detected in any of the participants. In an age-matched case-control analysis, 16/18 (89%) cases had not taken ivermectin the year before they developed epilepsy, compared to 7/18 (39%) controls that same year (p=0.002).

conclusionsThese data suggest that frequent activities at rivers known to be blackfly breeding sites and a historical lack of ivermectin treatment were risk factors for epilepsy in this onchocerciasis endemic area.

Indexed as

AdolescentAdultAnimalsCase-Control StudiesChildChild, PreschoolDemocratic Republic of the CongoEpilepsyFemaleHumansIvermectinMaleMiddle AgedOnchocerca volvulusOnchocerciasisPrevalenceIvermectinCase-control studyDemocratic Republic of the CongoEpilepsyNodding syndromeOnchocerciasisRisk factors

Identifiers

PMID27210267
PMCPMC4973807
OpenAlexW2406804354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.